Terms: = Leukemia AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30 AND Clinical Outcome
6 results:
1. [Current management and new treatment strategies of chronic myeloid leukemia].
Crysandt M; Brümmendorf TH
Dtsch Med Wochenschr; 2023 Jun; 148(12):744-751. PubMed ID: 37257476
[TBL] [Abstract] [Full Text] [Related]
2. Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies.
Lipowska-Bhalla G; Fagnano E; Illidge TM; Cheadle EJ
Leuk Lymphoma; 2016; 57(6):1269-80. PubMed ID: 27050042
[TBL] [Abstract] [Full Text] [Related]
3. Chronic lymphocytic leukemia: a clinical review including Korean cohorts.
Jeon YW; Cho SG
Korean J Intern Med; 2016 May; 31(3):433-43. PubMed ID: 27044858
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
[TBL] [Abstract] [Full Text] [Related]
5. NOTCH1 and fbxw7 mutations favor better outcome in pediatric South Indian T-cell acute lymphoblastic leukemia.
Natarajan V; Bandapalli OR; Rajkumar T; Sagar TG; Karunakaran N
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e23-30. PubMed ID: 25493453
[TBL] [Abstract] [Full Text] [Related]
6. How I treat hairy cell leukemia.
Grever MR
Blood; 2010 Jan; 115(1):21-8. PubMed ID: 19843881
[TBL] [Abstract] [Full Text] [Related]